Angela Garces
Adult Health · Mountain Lakes, NJNPI 1770174815
Payments from drug & device makers
Across 193 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$337
- GSK$286
- AstraZeneca$268
- Johnson & Johnson$243
- Novartis$182
- E.r. Squibb & Sons, L.L.C.$163
- plus $2K from 40 others
What the payments were for
- Food & beverage$3,27497%
- Education$923%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,366 in reported general payments places this provider in the 85th percentile of 1,135 adult health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrukinsaZanubrutinib | 32 | $472,200 |
| JakafiRuxolitinib Phosphate | 18 | $319,047 |
| ProcritEpoetin Alfa | 105 | $233,490 |
| SprycelDasatinib | 13 | $229,393 |
| CalquenceAcalabrutinib Maleate | 15 | $221,470 |
| XtandiEnzalutamide | 12 | $165,077 |
| HyqviaIgg/Hyaluronidase,recombinant | 16 | $151,306 |
| EliquisApixaban | 20 | $16,125 |
| XareltoRivaroxaban | 17 | $11,728 |
| Imatinib Mesylate | 20 | $1,089 |
| Letrozole | 28 | $942 |
| Prochlorperazine Maleate | 29 | $819 |
| Anastrozole | 51 | $706 |
| Hydroxyurea | 20 | $433 |
| Acyclovir | 28 | $408 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Beigene USA, Inc.Brukinsa | $17 | $472,20032 claims |
| Incyte CorporationJakafi | $130 | $319,04718 claims |
| Johnson & JohnsonProcrit, Xarelto | $243 | $245,217122 claims |
| E.r. Squibb & Sons, L.L.C.Sprycel | $163 | $229,39313 claims |
| AstraZenecaCalquence | $268 | $221,47015 claims |
| Astellas Pharma US IncXtandi | $98 | $165,07712 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Hyqvia | $40 | $151,30616 claims |
| PfizerEliquis | $58 | $16,12520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,135 adult health providers in New Jersey.
Other adult health in Mountain Lakes
- June HalperHackensack$458K
- Kara SaggiomoCamden$127K
- Entela AhmetiPomona$75K
- Phyllis McKiernanHackensack$72K
- Denise ForceMiddletown$71K
- Kathleen SenecaHillsborough$64K
- Diane AndresenNorthvale$60K
- Dana BeenstockFreehold$51K
- Phyllis DudaCamden$46K
- Anthony WalkoWestwood$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.